Rankia USA Rankia Argentina Rankia Brasil Rankia Chile Rankia Colombia Rankia Czechia Rankia Deutschland Rankia España Rankia France Rankia Indonesia Rankia Italia Rankia Magyarország Rankia México Rankia Netherlands Rankia Perú Rankia Polska Rankia Portugal Rankia Romania Rankia Türkiye Rankia United Kingdom
Acceder

Farmas USA

135K respuestas
Farmas USA
85 suscriptores
Farmas USA
Página
14,166 / 16,979
#113322

Re: Farmas USA

RVNC

Nota de Stifel de ayer noche:

Initiating coverage of Revance Therapeutics with a Buy Rating and $50 PT. The neurotoxin space — owned by Botox AGN — is finally evolving after years of innovation stagnation: everything from consumer marketing to value to product efficacy is getting a revamp. Unseating Botox may not be likely, but being the innovative product in a sea of “like” choices is an enviable position for RVNC, in our view. We estimate a procedure penetration of 20% share at peak, with potential for greater upside for both cosmetic and therapeutic.

#113325

Re: Farmas USA

En el Spy estan aguantando como jabatos el 262, de perderlo no se, no se (de todos modos esperaran como siempre al cierre EU).

Solo se que no se nada.

#113326

Re: Farmas USA

CNAT vamos que cerramos el gap

#113328

Re: Farmas USA

hoy el charles schwab ha colocado HZNP SEM Y NXGN como  recomendada dentro de small cap growth

Te puede interesar...

- No hay entradas a destacar -

- No hay entradas a destacar -

Brokers destacados